Update shared on 26 Nov 2025
Analysts have maintained their price target for Enact Holdings at $40.60 per share. This reflects stable long-term expectations alongside only modest adjustments to revenue growth and margin forecasts.
What's in the News
- Enact Holdings repurchased 3,983,192 shares from July 1, 2025 to October 31, 2025, representing 2.68% of the company for $147.09 million. (Key Developments)
- The company has now completed the repurchase of 6,365,825 shares, which is 4.26% of the outstanding shares, for a total amount of $231.84 million under the buyback announced on April 30, 2025. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target holds steady at $40.60 per share, reflecting unchanged market expectations for fair value.
- Discount Rate decreased slightly from 7.63% to 7.57%, indicating a modest reduction in the expected return required by investors.
- Revenue Growth forecast softened, moving from 3.69% to 3.41% annually.
- Net Profit Margin edged higher, rising from 47.25% to 47.64%.
- Future P/E ratio increased from 9.34x to 9.71x, which suggests a marginal uptick in the valuation multiple applied to projected earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.